Biomarkers and biosensors of delayed neuropathic agents

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 859-876

  Richardson, Rudy J ^a   Worden, R Mark ^b   Makhaeva, Galina F ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884736001     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374484-5.00057-2     Document Type: Chapter

References (127)

1. Abou-Donia M.B. Tri-phenyl phosphite: a type II organophosphorus compound-induced delayed neurotoxic agent. Organophosphates: Chemistry, Fate, and Effects 1992, 327-351. Academic Press, San Diego. J.E. Chambers, P.E. Levi (Eds.).
2. Akassoglou K., Malester B., Xu J., Tessarollo L., Rosenbluth J., Chao M.V. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc. Natl Acad. Sci. USA 2004, 101:5075-5080.
3. Aldridge W.N., Reiner E. Enzyme Inhibitors as Substrates: Interactions of Esterases with Esters of Organophosphorus and Carbamic Acids 1972, North-Holland Publishing Company, Amsterdam, 328 pp.
4. Atkins J., Glynn P. Membrane association of and critical residues in the catalytic domain of human neuropathy target esterase. J. Biol. Chem. 2000, 275:24477-24483.
5. Atkins J., Luthjens L.H., Hom M.L., Glynn P. Monomers of the catalytic domain of human neuropathy target esterase are active in the presence of phospholipid. Biochem. J 2002, 361:119-123.
6. Atkinson, A.J., Colburn, W.A., DeGruttola, V.G., DeMets, D.L., Downing, G.J., Hoth, D.F., Oates, J.A., Peck, C.C., Schooley, R.T., Spilker, B.A., Woodcock, J., Zeger, S.L. (Biomarkers Definitions Working Group) (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69: 89-95.
7. Barber D., Correll L., Ehrich M. Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. J. Toxicol. Environ. Health, Part A 1999, 57:63-74.
8. Bergveld P. The future of biosensors. Sensors and Actuators A:. Physical 1996, 56:65-73.
9. Bertoncin D., Russolo A., Caroldi S., Lotti M. Neuropathy target esterase in human lymphocytes. Arch. Environ. Health 1985, 40:139-144.
10. Clothier B., Johnson M.K. Rapid aging of neurotoxic esterase after inhibition by di-isopropylphosphorofluoridate. Biochem. J. 1979, 177:549-558.
11. Clothier B., Johnson M.K., Reiner E. Interaction of some trialkyl phosphorothiolates with acetylcholinesterase: characterization of inhibition, aging and reactivation. Biochim. Biophys. Acta 1981, 660:306-316.
12. Coche-Guerente L., Labbe P., Mengeaud V. Amplification of amperometric biosensor responses by electrochemical substrate recycling. 3. Theoretical and experimental study of the phenol-polyphenol oxidase system immobilized in Laponite hydrogels and layer-by-layer self-assembled structures. Anal. Chem. 2001, 73:3206-3218.
13. Davis C.S., Richardson R.J. Organophosphorus compounds. Experimental and Clinical Neurotoxicology 1980, 527-544. Williams and Wilkins, Baltimore. P.S. Spencer, H.H. Schaumburg (Eds.).
14. Davis C.S., Johnson M.K., Richardson R.J. Neurotoxicity of Industrial and Commercial Chemicals. Organophosphorus compounds 1985, Vol. II:1-23. CRC Press, Boca Raton. J.L. O'Donoghue (Ed.).
15. Davis S.L., Tanaka D., Aulerich R.J., Bursian S.J. Organophosphorus-induced neurotoxicity in the absence of neuropathy target esterase inhibition: the effects of triphenyl phosphine in the European ferret. Toxicol. Sci. 1999, 49:78-85.
16. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997, 277:1232-1237.
17. Decher G., Hong J.D. Buildup of ultrathin multilayer films by a self-assembly process: I. Consecutive adsorption of anionic and cationic bipolar amphiphiles on charged surfaces. Macromol. Chem. Macromol. Symp 1991, 46:321-327.
18. Decher G., Maclennan J., Sohling U., Reibel J. Creation and structural comparison of ultrathin film assemblies -transferred freely suspended films and Langmuir-Blodgett-films of liquid-crystals. Thin Solid Films 1992, 210:504-507.
19. Degenhardt C.E., Pleijsier K., Van der Schans M.J., Langenberg J.P., Preston K.E., Solano M.I., Maggio V.L., Barr J.R. Improvements of the fluoride reactivation method for the verification of nerve agent exposure. J. Anal. Toxicol. 2004, 28:364-371.
20. Doorn J.A., Gage D.A., Schall M., Talley T.T., Thompson C.M., Richardson R.J. Inhibition of acetylcholinesterase by (1 S,3 S)-isomalathion proceeds with loss of thiomethyl: kinetic and mass spectral evidence for an unexpected primary leaving group. Chem. Res. Toxicol. 2000, 13:1313-1320.
21. Doorn, J.A., Talley, T.T., Thompson, C.M., Richardson, R.J. (2001a). Probing the active sites of butyrylcholinesterase and cholesterol esterase with isomalathion: conserved stereoselective inactivation of serine hydrolases structurally related to acetylcholinesterase. Chem. Res. Toxicol.14: 807-13.
22. Doorn, J.A., Schall, M., Gage, D.A., Talley, T.T., Thompson, C.M., Richardson, R.J. (2001b). Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)-and (1S)-stereoisomers. Toxicol. Appl. Pharmacol.176: 73-80.
23. Doorn J.A., Thompson C.M., Christner R.B., Richardson R.J. Stereoselective interaction of Torpedo californica acetylcholinesterase by isomalathion: inhibitory reactions with (1 R)-and (1 S)-isomers proceed by different mechanisms. Chem. Res. Toxicol. 2003, 16:958-965.
24. Dudek, B.R., Richardson, R.J. (1978). Occurrence of neurotoxic esterase in various tissues of hen. Toxicol. Appl. Pharmacol. 45: 269-70 (abstract).
25. Dudek B.R., Richardson R.J. Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen. Biochem. Pharmacol. 1982, 31:1117-1121.
26. Elhanany E., Ordentlich A., Dgany O., Kaplan D., Segall Y., Barak R., Velan B., Shafferman A. Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts. Chem. Res. Toxicol. 2001, 14:912-918.
27. Eto M. Organophosphorus Pesticides: Organic and Biological Chemistry 1974, CRC Press, Cleveland, 387 pp.
28. Fioroni F., Moretto A., Lotti M. Triphenylphosphite neuropathy in hens. Arch. Toxicol 1995, 69:705-711.
29. Forzani E.S., Solis V.M., Calvo E.J. Electrochemical behavior of polyphenol oxidase immobilized in self-assembled structures layer by layer with cationic polyallylamine. Anal. Chem. 2000, 72:5300-5307.
30. Glynn P. Neuropathy target esterase. Biochem. J. 1999, 344:625-631.
31. Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase. Prog. Neurobiol. 2000, 61:61-74.
32. Glynn P. A mechanism for organophosphate-induced delayed neuropathy. Toxicol. Lett. 2006, 162:94-97.
33. Hassler B.L., Worden R.M. Versatile bioelectronic interfaces based on heterotrifunctional linking molecules. Biosen. Bioelectr. 2006, 21:2146-2154.
34. Hassler B.L., Kohli N., Zeikus J.G., Lee I., Worden R.M. Renewable dehydrogenase-based interfaces for bioelectronic applications. Langmuir 2007, 23:7127-7133.
35. Jennings L.L., Malecki M., Komives E.A., Taylor P. Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry. Biochemistry 2003, 42:11083-11091.
36. Jianmongkol S., Marable B.R., Berkman C.W., Talley T.T., Thompson C.M., Richardson R.J. Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1 R)-and (1 S)-stererisomers of isomalathion. Toxicol. Appl. Pharmacol. 1999, 155:43-53.
37. Johnson M.K. Organophosphorus and other inhibitors of brain "neurotoxic esterase' and the development of delayed neurotoxicity in hens. Biochem. J. 1970, 120:523-531.
38. Johnson M.K. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J. Neurochem. 1974, 23:785-789.
39. Johnson M.K. Structure-activity relationships for substrates and inhibitors of hen brain neurotoxic esterase. Biochem. Pharmacol. 1975, 24:797-805.
40. Johnson M.K. Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch. Toxicol 1977, 37:113-115.
41. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. Rev. Biochem. Toxicol. 1982, 4:141-212.
42. Johnson M.K. Organophosphates and delayed neurotoxicity -is NTE alive and well?. Toxicol. Appl. Pharmacol. 1990, 102:385-399.
43. Johnson M.K., Lotti M. Delayed neurotoxicity caused by chronic feeding of organophosphates requires a high point of inhibition of neurotoxic esterase. Toxicol. Lett. 1980, 5:99-102.
44. Johnson M.K., Read D.J. The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: neuropathic and prophylactic effects of stereoisomeric esters of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase. in vivo. Toxicol. Appl. Pharmacol. 1987, 90:103-115.
45. Johnson M.K., Read D.J., Benschop H.P. Interaction of the four stereoisomers of soman (pinacolyl methylphosphonofluoridate) with acetylcholinesterase and neuropathy target esterase of hen brain. Biochem. Pharmacol. 1985, 34:1945-1951.
46. Johnson M.K., Read D.J., Yoshikawa H. The effect of steric factors on the interaction of some phenylphosphonates with acetylcholinesterase and neuropathy target esterase of hen brain. Pestic. Biochem. Physiol. 1986, 23:133-142.
47. Johnson M.K., Willems J.L., De Bisschop H.C., Read D.J., Benschop H.P. High doses of soman protect against organophosphorus-induced delayed polyneuropathy but tabun does not. Toxicol. Appl. Pharmacol. 1988, 92:34-41.
48. Kayyali U.S., Moore T.B., Randall J.C., Richardson R.J. Neurotoxic esterase (NTE) assay: optimized conditions based on detergent-induced shifts in the phenol/4-aminoantipyrine chromophore spectrum. J. Anal. Toxicol. 1991, 15:86-89.
49. Kohli N., Worden R.M., Lee I. Intact transfer of layered, bionanocomposite arrays by microcontact printing. Chem. Commun. 2005, 3:316-318.
50. Kohli N., Hassler B.L., Parthasarathy L., Richardson R.J., Ofoli R.Y., Worden R.M., Lee I. Tethered lipid bilayers on electrolessly deposited gold for bioelectronic applications. Biomacromolecules 2006, 7:3327-3335.
51. Kohli, N., Srivastava, D., Sun, J., Richardson, R.J., Lee, I.S., Worden, R.M. (2007a). Nanostructured biosensor for measuring neuropathy target esterase activity. Anal. Chem.79: 5196-203.
52. Kohli, N., Worden, R.M., Lee, I. (2007b). Direct transfer of preformed patterned bio-nanocomposite films on polyelectrolyte multilayer templates. Macromol. Biosci.7: 789-97.
53. Kovacs G.T.A. Electronic sensors with living cellular components. Proc. IEEE 2003, 91:915-929.
54. Kropp T.J., Richardson R.J. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. J. Toxicol. Environ. Health Part A 2003, 66:1145-1157.
55. Kropp T.J., Richardson R.J. Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct. Chem. Res. Toxicol 2006, 19:334-339.
56. Kropp T.J., Richardson R.J. Mechanism of aging of mipafox-inhibited butyrylcholinesterase. Chem. Res. Toxicol 2007, 20:504-510.
57. Kropp T.J., Glynn P., Richardson R.J. The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry 2004, 43:3716-3722.
58. Li H., Schopfer L.W., Nachon F., Froment M.-T., Masson P., Lockridge O. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry. Toxicol. Sci. 2007, 100:136-145.
59. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol. 1992, 21:465-487.
60. Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin. Chem. 1995, 41:1814-1818.
61. Lotti M., Johnson M.K. Repeated small doses of a neurotoxic organophosphate: monitoring of neurotoxic esterase in brain and spinal cord. Arch. Toxicol. 1980, 45:263-271.
62. Lotti M., Moretto A. Organophosphate-induced polyneuropathy. Toxicol. Rev. 2005, 24:37-49.
63. Lotti M., Becker C.E., AminoffM.J., Woodrow J.E., Seiber J.N., Talcott R.E., Richardson R.J. Occupational exposure to the cotton defoliants DEF and merphos. A rational approach to monitoring organophosphorous-induced delayed neurotoxicity. J. Occup. Med. 1983, 25:517-522.
64. Lotti M., Moretto A., Zoppellari R., Dainese R., Rizzuto N., Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch. Toxicol. 1986, 59:176-179.
65. Lush M.J., Li Y., Read D.J., Willis A.C., Glynn P. Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem. J. 1998, 332:1-4.
66. Lvov Y., Haas H., Decher G., Mohwald H., Mikhailov A., Mtchedlishvily B., Morgunova E., Vainshtein B. Successive deposition of alternate layers of polyelectrolytes and a charged virus. Langmuir 1994, 10:4232-4236.
67. Main A.R. Cholinesterase inhibitors. Introduction to Biochemical Toxicology 1980, 193-223. Elsevier, New York. E. Hodgson, F.E. Guthrie (Eds.).
68. Makhaeva G.F., Sigolaeva L.V., Zhuravleva L.V., Eremenko A.V., Kurochkin I.N., Richardson R.J., Malygin V.V. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. J. Toxicol. Environ. Health Part A 2003, 66:599-610.
69. Makhaeva G.F., Malygin V.V., Strakhova N.N., Sigolaeva L.V., Sokolovskaya L.G., Eremenko A.V., Kurochkin I.N., Richardson R.J. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Hum. Exp. Toxicol. 2007, 26:273-282.
70. Malygin V.V., Sokolov V.B., Richardson R.J., Makhaeva G.F. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates. J. Toxicol. Environ. Health Part A 2003, 66:611-625.
71. Maroni M., Bleecker M.L. Neuropathy target esterase in human lymphocytes and platelets. J. Appl. Toxicol 1986, 6:1-7.
72. Marrs T.C., Maynard R.L., Sidell F.R. Chemical Warfare Agents: Toxicology and Treatment 1996, John Wiley and Sons, Chichester, pp. 88-137.
73. Masson P., Fortier P.L., Albaret C., Froment M.T., Bartels C.F., Lockridge O. Aging of di-isopropyl-phosphorylated human butyrylcholinesterase. Biochem. J. 1997, 327:601-607.
74. McConnell R., Delgado-Téllez E., Cuadra R., Tórres E., Keifer M., Almendárez J., Miranda J., El-Fawal H.A., WolffM., Simpson D., Lundberg I. Organophosphate neuropathy due to methamidophos: biochemical and neurophysiological markers. Arch. Toxicol. 1999, 73:296-300.
75. McFadden P. Broadband detection: Holmes on a chip. Science 2002, 297:2075-2076.
76. Michel H.O., Hackley B.E., Berkowitz L., List G., Hackley E.B., Gillilan W., Pankau M. Ageing and dealkylation of soman (pinacolylmethylphosphonofluoridate)-inactivated eel cholinesterase. Arch. Biochem. Biophys. 1967, 121:29-34.
77. Milatovic D., Johnson M.K. Reactivation of phosphoramidated acetylcholinesterase and neuropathy target esterase by treatment of inhibited enzyme with potassium fluoride. Chem. Biol. Interact. 1993, 87:425-430.
78. Millard, C.B., Kryger, G., Ordentlich, A., Greenblatt, H.M., Harel, M., Raves, M.L., Segall, Y., Barak, D., Shafferman, A., Silman, I., Sussman, J.L. (1999a). Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. Biochemistry38: 7032-9.
79. Millard, C.B., Koellner, G., Ordentlich, A., Shafferman, A., Silman, I., Sussman, J. (1999b). Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad. J. Am. Chem. Soc.121: 9883-4.
80. Moser M., Li Y., Vaupel K., Kretzschmar D., Kluge R., Glynn P., Buettner R. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol. Cell Biol. 2004, 24:1667-1679.
81. Mühlig-Versen, M., da Cruz, A.B., Tschäpe, J.A., Moser, M., Büttner, R., Athenstaedt, K., Glynn, P., Kretzschmar, D. (2005). Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila. J. Neurosci. 25: 2865-73.
82. Nolan M.A., Tan S.H., Kounaves S.P. Fabrication and characterization of a solid state reference electrode for electroanalysis of natural waters with ultramicroelectrodes. Anal. Chem. 1997, 69:1244-1247.
83. Novak R., Padilla S. An in vitro comparison of rat and chicken brain neurotoxic esterase. Fundam. Appl. Toxicol. 1986, 6:464-471.
84. Ordentlich A., Barak D., Kronman C., Ariel N., Segall Y., Velan B., Shafferman A. The architecture of human acetylcholinesterase active center probed with selected organophosphate inhibitors. J. Biol. Chem. 1996, 271:11953-11962.
85. Ordentlich A., Barak D., Kronman C., Ariel N., Segall Y., Velan B., Shafferman A. Functional characteristics of the oxyanion hole in human acetylcholinesterase. J. Biol. Chem. 1998, 273:19509-19517.
86. Padilla S.S., Grizzle T.G., Lyerly D. Triphenyl phosphite: in vivo and in vitro inhibition of rat neurotoxic esterase. Toxicol. Appl. Pharmacol. 1987, 87:249-256.
87. Peteu S.F., Emerson D., Worden R.M. A Clark-type oxidase enzyme-based amperometric microbiosensor for sensing glucose, galactose, or choline. Biosens. Bioelectr. 1996, 11:1059-1071.
88. Peteu S.F., Widman M.T., Worden R.M. In situ mapping of community-level cellular response with catalytic microbiosensors. Biosens. Bioelectr. 1998, 13:1197-1203.
89. Prodromidis M.I., Karayannis M.I. Enzyme based amperometric biosensors for food analysis. Electroanalysis 2002, 14:241-261.
90. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Natl Acad. Sci. USA 2003, 100:7983-7987.
91. Rabbany S.Y., Donner B.L., Ligler F.S. Optical immunosensors. Crit. Rev. Biomed. Eng. 1994, 22:307-346.
92. RaffM.C., Whitmore A.V., Finn J.T. Axonal self-destruction and neurodegeneration. Science 2002, 296:868-871.
93. Rainier S., Bui M., Mark E., Thomas D., Tokarz D., Ming L., Delaney C., Richardson R.J., Albers J.W., Matsunami N., Stevens J., Coon H., Leppert M., Fink J.K. Neuropathy target esterase gene mutations cause motor neuron disease. Am. J. Hum. Genet. 2008, 82:780-785.
94. Raisi F., Blizard B.A., Shabari A.R., Ching J., Kintz G.J., Mitchell J., LemoffA., Taylor M.T., Weir F., Western L., Wong W., Joshi R., Howland P., Chauhan A., Nguyen P., Peterson K.E. Human genomic DNA analysis using a semi-automated sample preparation, amplification, and electrophoresis separation platform. J. Separation Sci. 2004, 27:275-283.
95. Richardson R.J. Neurotoxic esterase. Cellular and Molecular Neurotoxicology 1984, 285-295. Raven Press, New York, normal and pathogenic roles. T. Narahashi (Ed.).
96. Richardson R.J. Interactions of organophosphorus compounds with neurotoxic esterase. Organophosphates: Chemistry, Fate, and Effects 1992, 299-323. Academic Press, San Diego. J.E. Chambers, P.E. Levi (Eds.).
97. Richardson R.J. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. J. Toxicol. Environ. Health 1995, 44:135-165.
98. Richardson, R.J. (2005). Organophosphate poisoning, delayed neurotoxicity. In Encyclopedia of Toxicology, 2nd edition (4 vols) (P. Wexler, ed.), Vol. 3, pp. 302-6. Elsevier, Oxford.
99. Richardson, R.J., Dudek, B.R. (1983). Neurotoxic esterase: characterization and potential for a predictive screen for exposure to neuropathic organophosphates. In Pesticide Chemistry: Human Welfare and the Environment, Vol. 3 (J. Miyamoto, P.C. Kearney, eds), pp. 4915. Pergamon Press, Oxford.
100. Richardson R.J., Moore T.B., Kayyali U.S., Fowke J.H., Randall J.C. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: application to assessment of neuropathic risk. Fundam. Appl. Toxicol. 1993, 20:273-279.
101. Ruths J., Essler F., Decher G., Riegler H. Polyelectrolytes I: polyanion/polycation multilayers at the air/monolayer/water interface as elements for quantitative polymer adsorption studies and preparation of hetero-superlattices on solid surfaces. Langmuir 2000, 16:8871-8878.
102. Schmidt R., Decher G., Mesini P. Toward folding control in oligomers and polymers. Tetrahedron Lett. 1999, 40:1677-1680.
103. Schwab B.W., Richardson R.J. Lymphocyte and brain neurotoxic esterase: dose and time dependence of inhibition in the hen examined with three organophosphorus esters. Toxicol. Appl. Pharmacol. 1986, 83:1-9.
104. Shafferman A., Ordentlich A., Barak D., Stein D., Ariel N., Velan B. Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active site. Biochem. J. 1996, 318:833-840.
105. Sidell F.R., Borak J. Chemical warfare agents: II. Nerve agents. Ann. Emerg. Med. 1992, 21:865-871.
106. Solano M.I., Thomas J.D., Taylor J.T., McGuire J.M., Jakubowski E.M., Thomson S.A., Maggio V.L., Holland K.E., Smith J.R., Capacio B., Woolfitt A.R., Ashley D.L., Barr J.R. Quantification of nerve agent VX-butyrylcholinesterase adduct biomarker from an accidental exposure. J. Anal. Toxicol 2008, 32:68-72.
107. Suzuki H. Advances in the microfabrication of electrochemical sensors and systems. Electoanalysis 2000, 12:703-715.
108. Suzuki H., Hirakawa T., Sasaki S., Karube I. An integrated three-electrode system with a micromachined liquid-junction Ag/AgCl reference electrode. Anal. Chim. Acta 1999, 387:103-112.
109. Tanaka D., Bursian S.J., Lehning E.J., Aulerich R.J. Exposure to triphenyl phosphite results in widespread degeneration in the mammalian central nervous system. Brain Res. 1990, 531:294-298.
110. Thompson C.M., Richardson R.J. Anticholinesterase insecticides. Pesticide Toxicology and International Regulation (Current Toxicology Series) 2004, 89-127. John Wiley & Sons, Chichester. T.C. Marrs, B. Ballantyne (Eds.).
111. UNIPROT (2008). http://www.uniprot.org/uniprot/Q8IY17.
112. Urban G. Biosensor microsystems. Sensors Update 2000, 8:189-214.
113. Van der Schans M.J., Fidder A., Van Oeveren D., Hulst A.G., Noort D. Verification of exposure to cholinesterase inhibitors: generic detection of OPCW Schedule 1 nerve agent adducts to human butyrylcholinesterase. J. Anal. Toxicol. 2008, 32:125-130.
114. Van Tienhoven M., Atkins J., Li Y., Glynn P. Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J. Biol. Chem. 2002, 277:20942-20948.
115. Vo-Dinh T., Griffin G., Stokes D.L., Wintenberg A. Multi-functional biochip for medical diagnostic and pathogen detection. Sensors Actuators B. Chemical 2003, 90:104-111.
116. Vose S.C., Holland N.T., Eskenazi B., Casida J.E. Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants. Toxicol. Appl. Pharmacol 2007, 224:98-104.
117. Wijeyesakere S.J., Richardson R.J., Stuckey J.A. Modeling the tertiary structure of the patatin domain of neuropathy target esterase. Protein J 2007, 26:165-172.
118. Williams D.G. Intramolecular group transfer is a characteristic of neurotoxic esterase and is independent of the tissue source of the enzyme. Biochem. J. 1983, 209:817-829.
119. Williams D.G., Johnson M.K. Gel electrophoretic identification of hen brain neurotoxic esterase, labeled with tritiated diisopropylphosphorofluoridate. Biochem. J. 1981, 199:323-333.
120. Wilson B.W., Henderson J.D. Blood esterase determinations as markers of exposure. Rev. Environ. Contam. Toxicol. 1992, 128:55-69.
121. Winrow C.J., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat. Genet. 2003, 33:477-485.
122. Wu S.Y., Casida J.E. Neuropathy target esterase inhibitors: enantiomeric separation and stereospecificity of 2-substituted-4 H-l,3,2-benzodioxaphosphorin 2-oxides. Chem. Res. Toxicol. 1994, 7:77-81.
123. Wu S.Y., Casida J.E. Ethyl octylphosphonofluoridate and analogs: optimized inhibitors of neuropathy target esterase. Chem. Res. Toxicol. 1995, 8:1070-1075.
124. Wu S.Y., Casida J.E. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Toxicol. Appl. Pharmacol. 1996, 139:195-202.
125. Yun K.-S., Joo S., Kim H.-J., Kwak J., Yoon E. Silicon micromachined infrared thin-layer cell for in situ spectroelectrochemical analysis of aqueous and nonaqueous solvent system. Electroanalysis 2004, 17:959-964.
126. Zaccheo O., Dinsdale D., Meacock P.A., Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J. Biol. Chem. 2004, 279:24024-24033.
127. Ziegler C. Cell-based biosensors. Fresenius J. Anal. Chem. 2000, 366:552-559.